Laurus Labs Q1 Results
- BSE: 540222
- NSE: LAURUSLABS
- ISIN: INE947Q01028
- Sector: Biotechnology & Drugs
BSE
1,840.00
-32.15 (-1.72%)
-32.15 (-1.72%)Volume41.69 K
Updated: Fri 4 Sep, 2026 | 15:58:26
NSE
1,840.00-28.50 (-1.53%)
-28.50 (-1.53%)Volume1.08 M
Updated: Fri 4 Sep, 2026 | 15:51:22
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹2,026.31 Cr.(29.10%)
- Operating Profit₹514.40 Cr.(93.90%)
- Profit After Tax₹367.60 Cr.(125.49%)
- Operating Margin25.39%(50.19%)
Note: Comparison is on YoY basis
Quarterly - Laurus Labs Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,511.91 | 1,421.56 | 6.36% | 1,129.77 | 15.92% |
| Depreciation/ Amortization | 123.87 | 122.10 | 1.45% | 106.66 | 6.02% |
| Operating Income | 514.40 | 390.01 | 31.89% | 65.14 | 93.90% |
| Net Income | 367.60 | 279.14 | 31.69% | 12.42 | 125.49% |
| Other Operating Expenses Total | 373.33 | 363.51 | 2.70% | 312.28 | 11.35% |
| Net Income Before Taxes | 481.36 | 361.37 | 33.20% | 18.46 | 114.68% |
| Total Revenue | 2,026.31 | 1,811.57 | 11.85% | 1,194.91 | 29.10% |
| Selling/ General/ Admin Expenses Total | 258.70 | 235.85 | 9.69% | 173.98 | 20.44% |
| Diluted Normalized EPS | 6.80 | 5.17 | 31.65% | 0.23 | 125.17% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.